Immunogenicity and Safety of the New Inactivated Quadrivalent Influenza Vaccine Vaxigrip Tetra: Preliminary Results in Children ≥6 Months and Older Adults by Emanuele Montomoli, Alessandro Torelli, Ilaria Manini, Elena Gianchecchi

Subjects: “…Vaxigrip Tetra…”
Get full text

Comparative Assessment of Reactogenicity and Immunogenicity of Commercial Influenza Inactivated Vaccines: Polymer-Subunit Grippol plus, Subunit Influvac, Split Vaccine Waxigrip by S. M. Kharit, D. A. Lioznov, A. A. Ruleva, I. V. Fridman, N. V. Chirun, V. A. Aprjatina

Subjects: Get full text

Immunogenicity and safety of the first indigenously developed Indian tetravalent influenza vaccine (split virion) in healthy adults ≥ 18 years of age: A randomized, multicenter, ph... by Shrikant Sharma, Veer Bahadur Singh, Sanjay Kumar, Vipul Prajapati, Jitendra Patel, Rajesh Vukkala, Sanjay Kumar Jangid, Jayesh Sanmukhani, Gaurav Gupta, Pradip Patel, Ravindra Mittal, Reinhard Glueck

Subjects: Get full text

Clinical trial of tolerability, safety, and immunogenicity of the Russian influenza inactivated split vaccine Flu-m in children from 6 months to 9 years of age by A. M. Korolyuk, L. A. Zazimko, V. N. Kraeva, Yu. A. Koromzin, E. A. Ruzanova, A. A. Ekimov, N. N. Savina, E. V. Ryskova, V. P. Trukhin

Subjects: Get full text

Enhanced passive safety surveillance of a quadrivalent inactivated split virion influenza vaccine in Finland during the influenza season 2020/21 by Olga Syrkina, Ajinkya Inamdar, Sophie Wague, Céline Monfredo, Markku Nissilä, Anne-Laure Chabanon, Laurence Serradell

Subjects: Get full text

Enhanced passive safety surveillance of high-dose and standard-dose quadrivalent inactivated split-virion influenza vaccines in Germany and Finland during the 2022/23 influenza sea... by Marina Amaral de Avila Machado, Sonja Gandhi-Banga, Sophie Gallo, Tathyana Giannotti Cousseau, Reddappa Maniganahally Byrareddy, Markku Nissilä, Jörg Schelling, Celine Monfredo

Subjects: Get full text

Immunogenicity and safety of the first indigenously developed Indian tetravalent influenza vaccine (split virion) in healthy children (6 months to 17 years of age): a randomized, m... by Sumantra Sarkar, Chandrakant Bokade, Kapil Garg, Ravi Kumar, Jayesh Sanmukhani, Ravindra Mittal

Subjects: Get full text

Enhanced passive safety surveillance of the quadrivalent inactivated split-virion influenza vaccine (IIV4) in Finland during the 2019/20 influenza season by Anne-Laure Chabanon, Sophie Wague, Annick Moureau, Markku Nissila, Laurence Serradell

Subjects: Get full text